Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Making The Most Of A Maturing Myriad Genetics

Feb 17 2015

• By Mark Ratner

Related Content

The Alzheimer's Divide

Sep 01 2008

Option Deal Structure Works For Myriad As It Moves To Buy Crescendo

Feb 10 2014

Genomics Through The Lens Of Precompetitive Data Sharing

Jan 23 2012

FDA Plan To Regulate LDTs Includes Long Phase-In, Unmet-Need Exceptions

Jul 31 2014

Myriad Enters Companion Diagnostics Field With An FDA First

Jan 01 2015

Genentech and Inotek Pair Up in PARP Inhibition

Sep 01 2006

Myriad Gets Mixed Decision in Supreme Court; Biotech Industry Fears Fallout

Jun 17 2013

Genomics and Proteomics Forays into Psychiatric Illness

May 01 2007

Related Companies

Myriad Genetics, Inc.

Exact Sciences Corp.

Hologic, Inc.

Rules-Based Medicine

Myriad Genetics, Inc.

AstraZeneca PLC

AstraZeneca PLC

BioMarin Pharmaceutical Inc.

Tesaro, Inc.

AbbVie Inc.

Johnson & Johnson

Johnson & Johnson

Foundation Medicine, Inc.

Roche Holding AG

Sanofi

Qiagen NV

Invitae Corporation

Additional Topics

Strategy Clinical Trials Innovation Legal Issues Regulation Reimbursement Personalized Medicine Medical Device BioPharmaceutical

More from Innovation

More from In Vivo

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window